CN116693639A - Plant immunity activated egg CfCE61 secreted by fruit anthracis and application thereof - Google Patents
Plant immunity activated egg CfCE61 secreted by fruit anthracis and application thereof Download PDFInfo
- Publication number
- CN116693639A CN116693639A CN202310392875.XA CN202310392875A CN116693639A CN 116693639 A CN116693639 A CN 116693639A CN 202310392875 A CN202310392875 A CN 202310392875A CN 116693639 A CN116693639 A CN 116693639A
- Authority
- CN
- China
- Prior art keywords
- plant
- cfce61
- fruit
- secreted
- immune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013399 edible fruits Nutrition 0.000 title claims abstract description 24
- 230000036039 immunity Effects 0.000 title claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 73
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 45
- 230000028993 immune response Effects 0.000 claims abstract description 8
- 208000035240 Disease Resistance Diseases 0.000 claims abstract description 7
- 230000007123 defense Effects 0.000 claims abstract description 7
- 230000005934 immune activation Effects 0.000 claims abstract description 6
- 239000013604 expression vector Substances 0.000 claims description 19
- 230000003213 activating effect Effects 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 14
- 241000589158 Agrobacterium Species 0.000 claims description 13
- 230000014509 gene expression Effects 0.000 claims description 11
- 239000013612 plasmid Substances 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 8
- 239000013598 vector Substances 0.000 claims description 8
- 241000193738 Bacillus anthracis Species 0.000 claims description 7
- 230000001939 inductive effect Effects 0.000 claims description 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 6
- 244000052616 bacterial pathogen Species 0.000 claims description 5
- 238000003259 recombinant expression Methods 0.000 claims description 5
- 108091006088 activator proteins Proteins 0.000 claims description 4
- 108091008146 restriction endonucleases Proteins 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- 125000000539 amino acid group Chemical group 0.000 claims description 2
- 238000012217 deletion Methods 0.000 claims description 2
- 230000037430 deletion Effects 0.000 claims description 2
- 238000005316 response function Methods 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 230000009261 transgenic effect Effects 0.000 claims description 2
- 230000003827 upregulation Effects 0.000 claims description 2
- 230000029087 digestion Effects 0.000 claims 2
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 238000006243 chemical reaction Methods 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 4
- 238000012271 agricultural production Methods 0.000 abstract description 3
- 230000000853 biopesticidal effect Effects 0.000 abstract description 3
- 238000009395 breeding Methods 0.000 abstract description 2
- 230000001488 breeding effect Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 210000000987 immune system Anatomy 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 description 52
- 241000208125 Nicotiana Species 0.000 description 19
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 19
- 235000014443 Pyrus communis Nutrition 0.000 description 16
- 241000220324 Pyrus Species 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 10
- 239000000872 buffer Substances 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000011347 resin Substances 0.000 description 8
- 229920005989 resin Polymers 0.000 description 8
- 241000233616 Phytophthora capsici Species 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000010839 reverse transcription Methods 0.000 description 6
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 5
- 238000011529 RT qPCR Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000012636 effector Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000017074 necrotic cell death Effects 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 240000001987 Pyrus communis Species 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 102000007863 pattern recognition receptors Human genes 0.000 description 3
- 108010089193 pattern recognition receptors Proteins 0.000 description 3
- 230000009465 prokaryotic expression Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- 241000221662 Sclerotinia Species 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000004665 defense response Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000006167 equilibration buffer Substances 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 235000011008 sodium phosphates Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000010474 transient expression Effects 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241001639769 Colletotrichum fructicola Species 0.000 description 1
- 238000011537 Coomassie blue staining Methods 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108091006054 His-tagged proteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 229930195731 calicheamicin Natural products 0.000 description 1
- HXCHCVDVKSCDHU-LULTVBGHSA-N calicheamicin Chemical compound C1[C@H](OC)[C@@H](NCC)CO[C@H]1O[C@H]1[C@H](O[C@@H]2C\3=C(NC(=O)OC)C(=O)C[C@](C/3=C/CSSSC)(O)C#C\C=C/C#C2)O[C@H](C)[C@@H](NO[C@@H]2O[C@H](C)[C@@H](SC(=O)C=3C(=C(OC)C(O[C@H]4[C@@H]([C@H](OC)[C@@H](O)[C@H](C)O4)O)=C(I)C=3C)OC)[C@@H](O)C2)[C@@H]1O HXCHCVDVKSCDHU-LULTVBGHSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- SXYIRMFQILZOAM-HVNFFKDJSA-N dihydroartemisinin methyl ether Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OC)O[C@H]4[C@]32OO[C@@]1(C)O4 SXYIRMFQILZOAM-HVNFFKDJSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- ZDXLFJGIPWQALB-UHFFFAOYSA-M disodium;oxido(oxo)borane;chlorate Chemical compound [Na+].[Na+].[O-]B=O.[O-]Cl(=O)=O ZDXLFJGIPWQALB-UHFFFAOYSA-M 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000005712 elicitor Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000012536 storage buffer Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention belongs to the field of biotechnology, and provides a plant immune activation egg CfCE61 secreted by fruit anthracnose and application thereof, wherein the plant immune activation egg CfCE61 can be identified by a plant immune system to generate immune response, and a new way is provided for improving plant resistance; the CfCE61 protein can induce plant defense reaction and provide new materials for synthesizing biopesticide; the invention can be applied to the aspects of improving the disease resistance of crop breeding, biopesticide and the like, is hopeful to improve the disease resistance of plants to epidemic diseases, thereby achieving the purposes of increasing yield and reducing medicine, and has wide application prospect in agricultural production.
Description
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a plant immunity activated egg CfCE61 secreted by fruit anthracis and application thereof.
Background
Anthrax species are important plant pathogens and can infect many plant hosts, and the resulting anthrax often poses serious damage to crops.
The pear anthracnose is an important fungal disease on pear trees, wherein the pear anthracnose caused by fruit anthracnose (Colletotrichum fructicola) is one of important diseases in main pear producing areas in China, and can occur in the growing period and the fruit ripening period of the pear trees, so that fruit rot and premature leaf drop are caused to cause weakening of tree vigor, the yield and quality of the pear trees are seriously influenced, and serious economic loss is caused to Chinese agricultural production.
The pear anthracnose is also called bitter rot and late rot, mainly caused by fruit, and can also infect branches, leaves and the like.
The pear anthracnose occurs to different degrees in the pear producing area of the yellow river hometown road of China, and has obvious harm to Dangshan pear in particular; in the year 2008, pear anthracnose is outbreak in Dangshan areas, the disease fruit rate reaches more than 70 percent, and the direct economic loss exceeds 7 hundred million yuan; at present, pear anthracnose is still one of the major hidden hazards threatening the safety of the human pear industry, and the development of the pear industry is greatly limited.
The effector is a kind of secreted protein which is transported to plant cells by fruit anthracnose, has important functions of regulating host physiology and immune response, and is a key for analyzing disease occurrence mechanism and plant disease resistance.
During infection of plants by pathogenic bacteria, the plants recognize effectors secreted by the pathogenic bacteria by means of pattern recognition receptors (Pattern Recognition Receptors, PRRs) on the cell surface, triggering the basic immune response of the plants. These factors that activate the plant immune response are commonly referred to as plant immune elicitors (Plant Immunity Inducer, PII), an important class of which is the plant immune activator protein.
At present, the identification of novel plant immunity induced antigen proteins secreted by pathogenic bacteria is the focus of attention of researchers at home and abroad.
Reference to the literature
1. Wu Liangqing, zhu Liwu, heng Wei, etc. Dangshan pear anthracnose pathogen identification and antibacterial agent screening [ J ]. Chinese agricultural science, 2010,43 (18): 3750-3758.
2.Zhang P F,Zhai L F,Zhang X K,et al.Characterization of Colletotrichum fructicola,a new causal agent of leaf black spot disease of sandy pear(Pyrus pyrifolia)[J].European Journal of Plant Pathology,2015,143(4):651-662.
3.Li H N,Jiang J J,Hong N,et al.First report of Colletotrichum fructicola causing bitter rot of pear(Pyrus bretschneideri)in China[J].Plant Disease,2013,97(7):1000-1000.
4.Shang S,Wang B,Zhang S,et al.A novel effector CfEC92 of Colletotrichum fructicola contributes to glomerella leaf spot virulence by suppressing plant defences at the early infection phase[J].Molecular plant pathology,2020,21(7):936-950.
5.Jones J D G,Dangl J L.The plant immune system[J].nature,2006,444(7117):323-329.
Disclosure of Invention
The invention aims to provide an effector molecule CfCE61 of fruit anthracnose, which has the activity of activating plant immunity.
Another object of the present invention is to provide the gene sequence of the effector molecule CfCE61 of the fruit-borne anthrax.
It is still another object of the present invention to provide a recombinant expression vector containing a gene encoding plant immune activator protein CfCE61.
It is still another object of the present invention to provide the use of the above-mentioned protein CfCE61 and its coding gene for activating plant immune response.
The aim of the invention can be achieved by the following technical scheme: a plant immune activation protein CfCE61 secreted by fruit anthracis is as follows (a) or (b):
(a) Has the sequence shown in SEQ ID NO:2, a protein having an amino acid sequence shown in seq id no;
(b) Setting SEQ ID NO:2 by substitution and/or deletion and/or addition of one or several amino acid residues and associated with activating the plant immune response function, consisting of the amino acid sequence of SEQ ID NO: 2.
A gene encoding the plant immune activating protein CfCE 61; the gene can induce plant resistance and has a nucleotide sequence shown as SEQ ID NO. 1; the amino acid sequence of the plant immune activator protein CfCE61 is utilized to facilitate the expression in plants.
Recombinant expression vectors, expression cassettes, transgenic cell lines or recombinant bacteria containing the coding genes of the genes CfCE61.
The expression vector is obtained by inserting the gene into a plant expression vector pSuper vector and is obtained by double enzyme cutting of restriction enzymes XbaI and KpnI, and the recombinant expression vector is obtained by inserting the gene into a plant expression vector pET-28a and is obtained by double enzyme cutting of restriction enzymes BamHI and NdeI.
The method for improving the disease resistance of plants, improving the defensive power of the plants and improving the resistance of the plants to pathogenic bacteria is realized by a mode of secreting a plant immune activating protein CfCE61 of fruit anthracnose; the method specifically comprises the following steps:
s1: connecting the coding gene of the plant immunity activating protein CfCE61 secreted by the fruit anthracis to a plant reaching carrier, and then converting escherichia coli to obtain a recombinant plasmid;
s2: the recombinant plasmid was transferred into agrobacterium and transiently expressed on plants.
Preferably, the plant expression vector described in S1 is preferably a pSuper vector.
Preferably, the E.coli described in S1 is E.coli DH 5. Alpha.
Preferably, the agrobacterium described in S2 is preferably agrobacterium GV3101.
The application of the plant immune activation protein CfCE61 secreted by the fruit anthracnose in the aspect of inducing up-regulation of the expression of the plant defense related genes can be realized by expressing the plant immune activation protein CfCE61 secreted by the fruit anthracnose.
A method of inducing a plant resistance response comprising injecting into a plant leaf the plant immune activating protein CfCE61 described above.
Compared with the prior art, the invention has the following beneficial effects: the plant immune activating protein CfCE61 can be identified by a plant immune system to generate immune response, a new way is provided for improving plant resistance, the CfCE61 protein can induce plant defense response, and a new material is provided for synthesizing biological pesticides; the invention can be applied to the aspects of improving the disease resistance of crop breeding, biopesticide and the like, is hopeful to improve the disease resistance of plants to epidemic diseases, thereby achieving the purposes of increasing yield and reducing medicine, and has wide application prospect in agricultural production.
Drawings
FIG. 1 is a schematic diagram of a plant expression vector pSuper:: cfCE 61;
FIG. 2 is a Western blot detection chart of tobacco leaf allergic reaction detection and CfCE61 protein expression induced by injecting and expressing CfCE61 on tobacco leaves by using a plant expression vector, wherein the antibody is an anti-HA monoclonal antibody;
FIG. 3 shows SDS-PAGE and Coomassie brilliant blue staining of purified CfCE61 protein obtained by prokaryotic expression;
FIG. 4 is a diagram showing induction of expression of plant defense-related genes after injection of CfCE61 on tobacco leaves using a plant expression vector;
FIG. 5 is a graph showing the effect of plant immune activating protein CfCE61 on inducing tobacco to resist phytophthora capsici and a statistical graph of disease occurrence.
Detailed Description
The present invention will be described in further detail with reference to examples, but embodiments of the present invention are not limited thereto.
Unless specifically stated otherwise, the reagents, methods and apparatus employed in the present invention are those conventional in the art.
The test methods for specific experimental conditions are not noted in the examples below, and are generally performed under conventional experimental conditions or under experimental conditions recommended by the manufacturer.
The reagents and starting materials used in the present invention are commercially available unless otherwise specified.
The primers related to the embodiment of the invention are synthesized by Nanjing qingke biotechnology Co.
Embodiment one: cloning of coding genes
(1) Total RNA extraction: the method uses the fruit anthracnose mycelium as an experimental material, extracts total RNA by adopting an RNA extraction kit of Vazyme company, and detects the RNA content and quality by using a spectroscope according to the illustrated operation.
(2) Reverse transcription generates the first strand: 1. Mu.g of RNA was used as a template for cDNA synthesis according to the instructions of the Vazyme HiScript II reverse transcription kit.
Appropriate amounts of the reverse transcription product were taken for subsequent gene cloning PCR.
(3) Using cDNA as PCR template, amplifying the mature gene sequence of CfCE61 gene:
PCR primer amplification sequence:
an upstream primer: SEQ ID NO.3
TACACCAAATCGACTCTAGAATGGTCAACTCATTCGTC
A downstream primer: SEQ ID NO.4
GGAAATTCGAGCTCGGTACCCTACGAGGAAGTACACTTG
50. Mu.L of reaction system: 2X Phanta Max Mix Buffer. Mu.L, 10mM dNTPs 1. Mu.L, vazyme DNA Polymerase. Mu.L, template cDNA 2. Mu.L, and water to 50. Mu.L; the PCR amplification procedure comprises pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 15s, annealing at 58 ℃ for 15s, extension at 72 ℃ for 1min, circulation for 35 times, and extension at 72 ℃ for 5min; the PCR reaction products were subjected to fragment size verification by DNA agarose gel electrophoresis.
Adding nucleic acid dye into 1 Xelectrophoresis buffer solution according to the ratio of 1:1000, performing electrophoresis separation, recording the result, and cutting gel to recover PCR product.
The electrophoresis band is recovered by FastPure Gel DNA Extraction Mini Kit (Vazyme) (the PCR product band is the plant immune activating protein CfCE61 gene, and is sent to Nanjing qinghao company for sequencing, the sequence is shown as SEQ ID NO.1, and the coded amino acid sequence of the plant immune activating protein CfCE61 is shown as SEQ ID NO. 2).
The PCR product recovered from the cut gel was ligated according to the procedure described for XbaI and KpnI on a pSuper vector containing pSuper:: cfCE61 ligation product according to CloneExpress II One Step Cloning Kit (Vazyme).
Wherein the pSuper vector contains XbaI and KpnI cleavage sites.
The ligation product was transformed into E.coli competent cells DH5 a, plated with LB (containing 50. Mu.g/mL) plates, incubated at 37℃for 12h, and then subjected to colony PCR validation to pick up two positive clones, which were subjected to plasmid extraction according to plasmid extraction kit procedure (Vazyme) to extract plasmids, and sent to Nanjing engine company for sequencing.
The plasmid with correct sequence was transformed into Agrobacterium GV3101, and LB plates (calicheamicin 50. Mu.g/mL, rifampicin 50. Mu.g/mL) containing the corresponding antibiotics were applied, and after 48h incubation at 28℃colony PCR confirmed that the correct clone was picked for subsequent experiments.
Results: the plant expression vector pSuper is CfCE61, and the pattern diagram is shown in figure 1
Embodiment two: transient expression of CfCE61 in tobacco induces generation of necrosis response
(1) Agrobacterium culture
Agrobacterium GV3101 single colonies containing the relevant vector were picked from the plates, inoculated into 2mL LB liquid medium (containing 50. Mu.g/mL of kananamycin, 50. Mu.g/mL of rifampin) and incubated overnight at 200rpm on a constant temperature shaker at 28℃to an OD600 of 0.6. The cultured overnight GV3101 Agrobacterium solution was centrifuged at 6000g for 3min to collect the cells.
The bacterial cells were collected by centrifugation after suspending the bacterial cells in a buffer (composition: 10mM2- [ N-morpholino ] ethanesulfonic acid,10mM MgCl2,0.1mM acetosyringone pH5.6). After 2 times of repeated washing, the bacterial solutions were diluted with buffer solutions, and the final concentrations were 0.5 each.
(2) Transient expression of CfCE61 in tobacco leaves
The prepared Agrobacterium was injected into tobacco leaves using a 1mL syringe with the needle removed, and the tobacco was cultured in a greenhouse (22-25 ℃ C., 16h light/8 h dark) after injection.
(3) Detection of necrosis
After the agrobacterium is transiently expressed for 5 days, the necrosis of the leaves is observed, after obvious phenotype appears, the leaves are collected, and the leaves are photographed by a camera and stored.
(4) Western blot detection of CfCE61 protein accumulation
Taking a Bentonite sample injected by agrobacterium after 2d injection, putting the sample into liquid nitrogen for quick freezing, grinding the sample into powder by a grinder, and carefully loading the powder into a precooled 1.5mL centrifuge tube; adding protein lysis buffer (50mM Tris,pH7.5, 150mM NaCl,1mM EDTA,1%TritonX-100,1% sodium deoxycholate, 1mM PMSF,1%proteinase inhibitor cocktail (Sigma)), and placing on ice for lysis for 40min, and vortexing once every 10 min; the sample was put into a centrifuge, centrifuged at 13000rpm at 4℃for 10min, the supernatant was added to an equal volume of 2 XSDS-PAGE loading buffer (120 mM Tris, pH6.8, 20% glycerol, 4% SDS,0.04% bromophenol blue, 10% mercaptoethanol), boiled for 10min, and 10. Mu.L of the sample was separated by electrophoresis on SDS-PAGE gel for 1.5h at 120V.
After the reaction, the protein samples were transferred to PVDF membranes and the membranes were incubated with 5% pbst skim milk. After adding HA primary antibody (Sigma) diluted 1:2000 and incubating for 3h, the membrane was washed three times with PBST for 5min, and PVDF membrane was immersed in ECL luminescence solution (Cytiva) and then scanned for imaging.
Results: cfCE61 was able to induce tobacco leaf cell necrosis as shown in figure 2.
Example 3: production of a defense response by prokaryotic expression of CfCE61 and purification of the protein
(1) Construction of prokaryotic expression vectors
The cDNA library of the interaction of the fruit anthracnose and the pear is taken as a template, a specific primer is designed according to the enzyme cutting site of the carrier,
an upstream primer: SEQ ID NO.5
GTGCCGCGCGGCAGCCATATGGGGATCCTCTCCCCGCGC
A downstream primer: SEQ ID NO.6
ACGGAGCTCGAATTCGGATCCCTACGAGGAAGTACACTTG
The gene of interest was cloned using Phusion High-Fidelity DNA Polymerase (New England Biolabs). The cloning fragment was then ligated into the plant expression vector pET-28a using the ClonExp one-step cloning kit (Vazyme), the vector was transformed into E.coli DH 5. Alpha. Competent by heat shock, positive clones were picked up, shaken and plasmids were extracted, and verified by sequencing.
(2) Inducible expression and crude protein extraction
The correct plasmid obtained in the step (1) was transformed into E.coli BL21 (DE 3) competent by heat shock, and after kanamycin selection, single clones were picked up to 5mL LB,37℃and cultured at 200rpm for 10h. Expanded culture was performed in 100mL of LB at a ratio (1:100) until OD600 = 0.6, induced expression was performed by adding 0.3M IPTG, culturing at 16℃for 24h at 200rpm, collecting the cells by centrifugation for 10min, and washing twice with PBS buffer (pH 7.4). The bacterial cells were resuspended in lysis buffer (20mM Na2HPO4, 300mM NaCl,pH7.4,1mg/mL lysozyme,1mM PMSF,1.98mM mercaptoethanol), sonicated for 15min, centrifuged at 10000g for 10min, and the supernatant was aspirated to obtain CfCE61 crude protein.
(3) Protein purification
The column was packed with an appropriate amount of Ni-NTA (Thermo Scientific) resin.
The storage buffer is allowed to drain from the resin by gravity flow. Samples were prepared by mixing the protein extract with an equal volume of equilibration buffer (20 mM sodium phosphate, 300mM sodium chloride and 10mM imidazole; pH 7.4).
The column was equilibrated with twice the volume of the resin bed of equilibration buffer and the buffer was allowed to flow out of the column. The prepared protein extract was added to the resin and the flow-through was collected in a tube.
The flow-through is reapplied once if necessary to maximize adsorption. The resin was washed with twice the resin bed volume of wash buffer (25 mM imidazole in PBS; pH 7.4) and the effluent was collected.
This procedure was repeated using a new collection tube. His-tagged proteins were eluted from the resin with twice the resin bed volume of elution buffer (250 mM imidazole in PBS; pH 7.4). This procedure was repeated twice and each fraction was collected in a separate tube.
Dialysis was performed with PBS (20 mM sodium phosphate, 300mM sodium chloride; pH 7.4) buffer.
Results: the purified CfCE61 protein (His-CfCE 61) obtained was subjected to SDS-PAGE, and a distinct band of interest (about 23 kDa) was seen after Coomassie blue staining, as shown in FIG. 3.
Example 4: cfCE61 purified protein induces up-regulated expression of defense tobacco related genes
(1) Tobacco leaf injection CfCE61 purified protein
The His-CfCE61 purified protein obtained in example 3 was subjected to concentration measurement and diluted to 1. Mu.M. The diluted purified protein was injected into tobacco leaves using a 1mL syringe with the needle removed, while PBS Buffer was injected as a control (Buffer), and after completion of the injection, the purified protein was incubated in a greenhouse (22-25 ℃ C., 16h light/8 h dark).
(2) Total RNA extraction
Tobacco samples treated for 4h with CfCE61 purified protein are used as experimental materials, total RNA is extracted by adopting an RNA extraction kit of Vazyme company according to the description operation, and the RNA content and quality of the total RNA are detected by using a spectroscope.
(3) Reverse transcription to generate the first strand
1. Mu.g of RNA was used as a template for cDNA synthesis according to the instructions of the Vazyme HiScript II reverse transcription kit. Appropriate amounts of reverse transcription product were taken for subsequent real-time quantitative PCR reactions.
(4) Real-time quantitative PCR reaction
NbPR1 quantitative pre-primer: SEQ ID NO.7
CCGCCTTCCCTCAACTCAAC
NbPR1 post-quantification primer: SEQ ID NO.8
GCACAACCAAGACGTACTGAG
NbPR4 quantitative pre-primer: SEQ ID NO.9
GGCCAAGATTCCTGTGGTAGAT
Quantitative post primer for NbPR 4: SEQ ID NO.10
CACTGTTGTTTGAGTTCCTGTTCCT
NbCYP71D20 quantitative pre-primer: SEQ ID NO.11
AAGGTCCACCGCACCATGTCCTTAGAG
NbCYP71D20 post-quantification primer: SEQ ID NO.12
AAGAATTCCTTGCCCCTTGAGTACTTGC
The PCR reaction system contained 1. Mu.L of cDNA, realStar Fast SYBR qPCR Mix. Mu.L of each of the front and rear primers, 1. Mu.L of water, and 7. Mu.L of water.
The reaction procedure: 95 degrees for 2 minutes, 95 degrees for 15 seconds, 60 degrees for 30 seconds, step II should be 40 cycles.
The dissolution profile analysis procedure was: 95 degrees 15 seconds, 60 degrees 1 minute, 95 degrees 15 seconds.
Results: the 1. Mu. MCfCE61 purified protein was able to induce a large up-regulated expression of the tobacco defense related genes compared to the control (Buffer), as shown in FIG. 4.
Example 5: the CfCE61 purified protein enhances tobacco resistance to Sclerotinia sclerotiorum and Phytophthora capsici
(1) Tobacco leaf injection CfCE61 purified protein
The concentration of the purified protein obtained in example 3 was measured and diluted to 1. Mu.M.
The diluted purified protein was injected into tobacco leaves using a 1mL syringe with the needle removed, while PBS Buffer was injected as a control (Buffer), and after completion of the injection, the purified protein was incubated in a greenhouse (22-25 ℃ C., 16h light/8 h dark).
(2) Respectively inoculating sclerotinia sclerotiorum and phytophthora capsici on tobacco leaves
Sclerotinia sclerotiorum is a pathogen causing sclerotinia rot of colza, belongs to fungi, has wide host range and is harmful to crops; phytophthora capsici is a pathogen causing induction of pepper epidemic disease, belongs to oomycetes, and has important harm to farming. After 12h of protein induction, the treated leaves are respectively inoculated with sclerotinia sclerotiorum and phytophthora capsici which are prepared in advance, and finally placed in a greenhouse (22-25 ℃ C., 16h light/8 h dark) for culture.
Observing and counting the disease condition of the sclerotinia sclerotiorum after 24 hours and photographing; and after 36 hours, observing, counting and photographing the disease condition of phytophthora capsici.
Results: compared to the control (Buffer), 1 μm CfCE61 purified protein significantly enhanced tobacco leaf resistance to sclerotinia and phytophthora capsici as shown in fig. 5.
While embodiments of the present invention have been shown and described above for purposes of illustration and description, it will be understood that the above embodiments are illustrative and not to be construed as limiting the invention, and that variations, modifications, alternatives, and variations may be made to the above embodiments by one of ordinary skill in the art within the scope of the invention.
Sequence description:
full-length nucleotide sequence of CfCE61 gene: SEQ ID NO.1
ATGGTCAACTCATTCGTCAAGCTCTTCGCCTTCGCTGGCCTCGCCTCCGCCGGGATCCTCTCCCCGCGCCAGAACACGACGCCTGCTGTTGACATTACGGCGCTGACCAAGAACGTCACGGCCACTTCCGGAACCGGCGCCGTCAGCGCCGCGGGAACCTTGTCTCCCTTTGGAGGTATCGGAGTTGGTTGTGGCATCAACTGGGCTGAGGGCCAGTCTTTTGGAGGTGGTCTTCAATCCGGCTCGGACTCTTTCGGTCTCGGCGGCGGATTCACCATTACCAAGGACACCATGATCATTGGTCTTGGCATTGGAATCAACCCCATTAAGTTCAACTCCAGCGTGAACTATGAAGCTTCGACTAACGGCACCGTGACCATGACCTTCACCTCCACGACGGCGATCAAGTGCGAAGAGACCACCGTTGATGGCGTCAAGGGTGTCAAGTGTACTTCCTCGTAG
CfCE61 mature protein sequence: SEQ ID NO.2
MGILSPRQNTTPAVDITALTKNVTATSGTGAVSAAGTLSPFGGIGVGCGINWAEGQSFGGGLQSGSDSFGLGGGFTITKDTMIIGLGIGINPIKFNSSVNYEASTNGTVTMTFTSTTAIKCEETTVDGVKGVKCTSS
PCR primer amplification sequences in example 1:
an upstream primer: SEQ ID NO.3
TACACCAAATCGACTCTAGAATGGTCAACTCATTCGTC
A downstream primer: SEQ ID NO.4
GGAAATTCGAGCTCGGTACCCTACGAGGAAGTACACTTG
PCR primer amplification sequences in example 3:
an upstream primer: SEQ ID NO.5
GTGCCGCGCGGCAGCCATATGGGGATCCTCTCCCCGCGC
A downstream primer: SEQ ID NO.6
ACGGAGCTCGAATTCGGATCCCTACGAGGAAGTACACTTG
Real-time quantitative PCR reaction primers in example 4
NbPR1 quantitative pre-primer: SEQ ID NO.7
CCGCCTTCCCTCAACTCAAC
NbPR1 post-quantification primer: SEQ ID NO.8
GCACAACCAAGACGTACTGAG
NbPR4 quantitative pre-primer: SEQ ID NO.9
GGCCAAGATTCCTGTGGTAGAT
Quantitative post primer for NbPR 4: SEQ ID NO.10
CACTGTTGTTTGAGTTCCTGTTCCT
NbCYP71D20 quantitative pre-primer: SEQ ID NO.11
AAGGTCCACCGCACCATGTCCTTAGAG
NbCYP71D20 post-quantification primer: SEQ ID NO.12
AAGAATTCCTTGCCCCTTGAGTACTTGC。
Claims (10)
1. A plant immune activation egg CfCE61 secreted by fruit anthracis is either (a) or (b) as follows:
(a) Has the sequence shown in SEQ ID NO:2, a protein having an amino acid sequence shown in seq id no;
(b) Setting SEQ ID NO:2 by substitution and/or deletion and/or addition of one or several amino acid residues and associated with activating the plant immune response function, consisting of the amino acid sequence of SEQ ID NO: 2.
2. A gene encoding the plant immune activator protein CfCE61 of claim 1, which is capable of inducing plant resistance, having a nucleotide sequence as shown in SEQ ID No. 1.
3. A recombinant expression vector, expression cassette, transgenic cell line or recombinant bacterium comprising the gene encoding the gene CfCE61 of claim 2.
4. The expression vector of claim 2, wherein the gene is inserted into a plant expression vector pSuper vector, the gene is obtained by double digestion of restriction enzymes XbaI and KpnI, and the recombinant expression vector is obtained by double digestion of restriction enzymes BamHI and NdeI selected for inserting the gene into a plant expression vector pET-28 a.
5. The method for improving plant disease resistance, improving plant defense capacity and improving plant resistance to pathogenic bacteria according to claim 1 by means of plant immune activating protein CfCE61 secreted by fruit anthracnose; the method specifically comprises the following steps:
s1: connecting the coding gene of the plant immunity activating protein CfCE61 secreted by the fruit anthracis to a plant reaching carrier, and then converting escherichia coli to obtain a recombinant plasmid;
s2: the recombinant plasmid was transferred into agrobacterium and transiently expressed on plants.
6. The plant-immune-activating egg CfCE61 secreted by anthrax fruit as in claim 5, wherein: the plant expression vector is preferably a pSuper vector.
7. The plant-immune-activating egg CfCE61 secreted by anthrax fruit as in claim 5, wherein: the escherichia coli is preferably escherichia coli DH5 alpha.
8. The plant-immune-activating egg CfCE61 secreted by anthrax fruit as in claim 5, wherein: the agrobacterium is preferably agrobacterium GV3101.
9. The use of plant immune activating egg CfCE61 according to claim 1 for inducing up-regulation of expression of plant defense-related genes by expressing plant immune activating protein CfCE61 secreted by anthrax fruit.
10. A method of inducing a plant resistance response comprising injecting into a plant leaf the plant immune activating protein CfCE61 described above.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310392875.XA CN116693639A (en) | 2023-04-13 | 2023-04-13 | Plant immunity activated egg CfCE61 secreted by fruit anthracis and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310392875.XA CN116693639A (en) | 2023-04-13 | 2023-04-13 | Plant immunity activated egg CfCE61 secreted by fruit anthracis and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116693639A true CN116693639A (en) | 2023-09-05 |
Family
ID=87826568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310392875.XA Pending CN116693639A (en) | 2023-04-13 | 2023-04-13 | Plant immunity activated egg CfCE61 secreted by fruit anthracis and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116693639A (en) |
-
2023
- 2023-04-13 CN CN202310392875.XA patent/CN116693639A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10900051B2 (en) | Gene for improving plant disease resistance and use thereof | |
CA2315546C (en) | Constitutive maize promoters | |
CN104946665B (en) | GmMYB62Application in cultivating transgenic plant with improved stress resistance | |
CN110194790B (en) | Plant immune activator protein FoPII1 secreted by fusarium oxysporum and application thereof | |
CN110922457B (en) | Plant immune induced resistance protein FgPII1 secreted by fusarium graminearum and application thereof | |
WO2001006006A1 (en) | Environmental stress resistance gene | |
CN111690054B (en) | Pinctada martensii Kunitz type serine protease inhibitor gene, encoded protein and application | |
CN109022454A (en) | Protein and the application of a kind of cotton long fibre cance high-expression gene GhLFHE2 and its coding | |
CN110938118B (en) | Plant immune activation protein PC2 secreted by phytophthora infestans and application thereof | |
CN108822195B (en) | Protein with function of promoting growth of pollen tube of Dangshan pear, coding gene PbrTTS1 and application of coding gene PbrTTS1 | |
CN114437188A (en) | Peronophythora litchi secretory protein elicitor PlPeL8 and application thereof | |
CN102719451A (en) | Poncirus trifoliata basic helix-loop-helix (PtrbHLH) and application in improving cold resistance of plant | |
CN110894218B (en) | Plant immune activator protein SCR50 secreted by phytophthora infestans and application thereof | |
CA2724250C (en) | Chimeric compositions and methods for regulating plant gene expression | |
CN110862978B (en) | Preparation method of recombinant halophilic archaea protease | |
CN116590310A (en) | Application of pear transcription factor PbHLH164 in promoting fruit ripening | |
CN113929755B (en) | Plant immune activating protein secreted by downy mildew of grape, primer and application | |
CN108588088B (en) | Drought-resistant transcription factor PbrERF109, preparation method and application thereof, encoded protein and application thereof | |
CN116693639A (en) | Plant immunity activated egg CfCE61 secreted by fruit anthracis and application thereof | |
CN108164589B (en) | Plant fungal disease resistance protein GhGLP2 from cotton, and coding gene and application thereof | |
AU738953B2 (en) | Hm2 cDNA related polypeptides and methods of use | |
JP2011103864A (en) | Gene encoding protein having deoxynivalenol and nivalenol decomposing activity | |
US20140351998A1 (en) | Engineering plants for efficient uptake and utilization of urea to improve crop production | |
CN116874573A (en) | Plant immune activating protein CfCE24 secreted by fruit anthracnose and application thereof | |
CN114106119B (en) | Scoxoist gene of erythropsis pinicola and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |